Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle. Icosavax is a member of the AstraZeneca Group.
View Top Employees from Icosavax, Inc.| Website | http://www.astrazeneca.com |
| Employees | 70 (70 on RocketReach) |
| Founded | 2018 |
| Address | 1930 Boren Ave Suite 1000, Seattle, Washington 98101, US |
| Technologies |
JavaScript,
HTML,
PHP
+29 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Vaccine Development, Science and Engineering, Discovery Tools (Healthcare), Infectious Disease, Health Care, VLPs, RSV, Respiratory syncytial virus, Vaccines, Vaccine |
Looking for a particular Icosavax, Inc. employee's phone or email?
Icosavax, Inc. Questions
Adam Simpson is the Chief Executive Officer and Co-Founder of Icosavax, Inc..
70 people are employed at Icosavax, Inc..
Icosavax, Inc. is based in Seattle, Washington.
Top Icosavax, Inc. Employees
-
41
-
15+
-
15+
-
25+
-
25+
-
41
-
ViewAmi Brown
Senior Vice President, Regulatory Affairs at Icosavax, Inc.
New Hope, Pennsylvania, United States55+ -
5+4
-
44
Related Companies
